Stockreport

Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results [Yahoo! Finance]

Lantern Pharma Inc.  (LTRN) 
PDF current expansion cohort reinforcing these positive trends as enrollment accelerates in Japan and Taiwan, where 33-40% of NSCLC cases occur in never-smokers, positioning [Read more]